951
Views
0
CrossRef citations to date
0
Altmetric
Surgery

The outcomes of surgical treatment via transsphenoidal approach for patients with nonfunctioning pituitary adenoma: a single institution’s experience

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3135-3144 | Received 08 Feb 2022, Accepted 20 Oct 2022, Published online: 04 Nov 2022

References

  • Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and Central nervous system tumours diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(Suppl 2):ii1–56.
  • Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. Jama. 2017;317(5):516–524.
  • Ntali G, Wass JA. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary. 2018;21(2):111–118.
  • Chen L, White WL, Spetzler RF, et al. A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neurooncol. 2011;102(1):129–138.
  • Huang W, Molitch ME. Management of nonfunctioning pituitary adenomas (NFAs): observation. Pituitary. 2018;21(2):162–167.
  • Penn DL, Burke WT, Laws ER. Management of non-functioning pituitary adenomas: surgery. Pituitary. 2018;21(2):145–153.
  • Caton R. Notes of a case of acromegaly treated by operation. Br Med J. 1893;2(1722):1421–1423.
  • Schloffer H. Successful transnasal operation on a pituitary tumour. Wien Klin Wochenschr. 1907;20:621–623.
  • Phan K, Xu J, Reddy R, et al. Endoscopic endonasal versus microsurgical transsphenoidal approach for growth Hormone-Secreting pituitary Adenomas-Systematic review and Meta-Analysis. World Neurosurg. 2017;97:398–406.
  • Lee MH, Lee JH, Seol HJ, et al. Clinical concerns about recurrence of Non-Functioning pituitary adenoma. Brain Tumour Res Treat. 2016;4(1):1–7.
  • Dallapiazza RF, Grober Y, Starke RM, et al. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery. 2015;76(1):42–52. discussion 52–43.
  • Almeida JP, Tabasinejad R, Kalyvas A, et al. The importance of long term follow up after endoscopic pituitary surgery: Durability of results and tumour recurrence. Neurol India. 2020;68(Supplement):S92–s100.
  • Watts AK, Easwaran A, McNeill P, et al. Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: Results from a single Australian Centre. Clin Endocrinol (Oxf). 2017;87(3):264–271.
  • Bernat AL, Troude P, Priola SM, et al. Endoscopic endonasal pituitary surgery for nonfunctioning pituitary adenomas: Long-Term outcomes and management of recurrent tumours. World Neurosurg. 2021;146:e341–e350.
  • Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33(4):610–617. discussion 617–618.
  • Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol. 1976;15:261–273.
  • Randall RV, Scheithauer BW, Laws ER, Jr., et al. Pseudoprolactinomas. Trans Am Clin Climatol Assoc. 1983;94:114–121.
  • Cappabianca P, Cavallo LM, de Divitiis E. Endoscopic endonasal transsphenoidal surgery. Neurosurgery. 2004;55(4):933–940. discussion 940–931.
  • Alexander JM, Biller BM, Bikkal H, et al. Clinically nonfunctioning pituitary tumours are monoclonal in origin. J Clin Invest. 1990;86(1):336–340.
  • Zaidi HA, Awad AW, Bohl MA, et al. Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma. J Neurosurg. 2016;124(3):596–604.
  • Iglesias P, Arcano K, Triviño V, et al. Non-functioning pituitary adenoma underwent surgery: a multicenter retrospective study over the last four decades (1977-2015). Eur J Intern Med. 2017;41:62–67.
  • Kim JH, Lee JH, Lee JH, et al. Endoscopic transsphenoidal surgery outcomes in 331 nonfunctioning pituitary adenoma cases after a single surgeon learning curve. World Neurosurg. 2018;109:e409–e416.
  • Pablo A, Sofia B, Maximiliano T, et al. Endoscopic versus microscopic pituitary adenoma surgery: a single-center study. Neurol India. 2019;67(4):1015–1021.
  • Almutairi RD, Muskens IS, Cote DJ, et al. Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir (Wien). 2018;160(5):1005–1021.
  • Frank G, Pasquini E, Farneti G, et al. The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology. 2006;83(3-4):240–248.
  • Messerer M, De Battista JC, Raverot G, et al. Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus. 2011;30(4):E11.
  • Ammirati M, Wei L, Ciric I. Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2013;84(8):843–849.
  • Li A, Liu W, Cao P, et al. Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary adenoma: a systematic review and Meta-Analysis. World Neurosurg. 2017;101:236–246.
  • Agam MS, Wedemeyer MA, Wrobel B, et al. Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center. Neurosurg. 2018;130:1–8.
  • Zhou Z, Zuo F, Chen X, et al. Risk factors for postoperative cerebrospinal fluid leakage after transsphenoidal surgery for pituitary adenoma: a meta-analysis and systematic review. BMC Neurol. 2021;21(1):417.
  • Abe T, Matsumoto K, Kuwazawa J, et al. Headache associated with pituitary adenomas. Headache. 1998;38(10):782–786.
  • Little AS, Gardner PA, Fernandez-Miranda JC, et al. Pituitary gland recovery following fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenoma: results of a prospective multicenter study. Neurosurg. 2019;133:1–7.
  • Hensley CP, Burlette J. A nonfunctioning pituitary adenoma in a patient with dizziness. J Orthop Sports Phys Ther. 2011;41(5):364.
  • Fatemi N, Dusick JR, Mattozo C, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008;63(4):709–718. discussion 718–709.
  • Nomikos P, Ladar C, Fahlbusch R, et al. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas – a study on 721 patients. Acta Neurochir (Wien). 2004;146(1):27–35.
  • Webb SM, Rigla M, Wägner A, et al. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab. 1999;84(10):3696–3700.
  • Mooney MA, Sarris CE, Zhou JJ, TRANSSPHER Study Group, et al. Proposal and validation of a simple grading scale (TRANSSPHER grade) for predicting gross total resection of nonfunctioning pituitary macroadenomas after transsphenoidal surgery. Oper Neurosurg (Hagerstown). 2019;17(5):460–469.
  • Greenman Y, Ouaknine G, Veshchev I, et al. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf). 2003;58(6):763–769.